SIMCERE PHARMACEUTICAL GROUP Accounts Receivable, Credit Loss Expense (Reversal)
SIMCERE PHARMACEUTICAL GROUP reported Accounts Receivable, Credit Loss Expense (Reversal) of -CNY 618.00 thousand for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2013-04-26
CNY
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2012-12-31 | -618.00K CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 994.00K CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 843.00K CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 101.00K CNY 20-F · filed 2012-04-25 |
USD
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2012-12-31 | -$99.00K 20-F · filed 2013-04-26 |